P.-A. Löschmann

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

Norbert Sommer, P.-A. Löschmann, G.H. Northoff et al. · Nature Medicine · 1995 · 343 citations

Inflammation, Psychoneuroimmunology, Autoimmune Disease +12

Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones

Ullrich Wüllner, P.-A. Löschmann, Jörg B. Schulz et al. · Neuroreport · 1996 · 152 citations

Mpp+ Toxicity, Neurotransmitter, Experimental Pharmacology +17

Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease

P.-A. Löschmann, Klaus W. Lange, Margrit Kunow et al. · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 1991 · 134 citations · Full text

Neurophysiology, Ampa-antagonist Nbqx, Medicine +10

Therapeutic potential of phosphodiesterase type 4 inhibition in chronic autoimmune demyelinating disease

Norbert Sommer, Henry F. McFarland, Laura Quigley et al. · Journal of Neuroimmunology · 1997 · 78 citations

Therapeutic Potential, Autoimmune Disease, Immunotherapy +12

The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist

Thomas Klockgether, P. JACOBSEN, P.-A. Löschmann et al. · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · 1993 · 53 citations

Antiparasitic Agent, Medicine, Neuropharmacology +5